According to the latest data from the Hong Kong Stock Exchange, on March 11, Wellington Management Group LLP purchased an additional 49,600 shares of Hengrui Pharma (01276). The transaction was executed at a price of HK$66.1267 per share, amounting to a total investment of approximately HK$3.2799 million. Following this acquisition, Wellington Management's total shareholding in the company has reached approximately 23.2444 million shares, representing a 9.00% stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments